Thesis
Onto Innovation sells the inspection, metrology, and process-control tools that help chipmakers detect what is going wrong before those defects become expensive yield losses. The most important point is that advanced packaging and HBM are not just adding more steps. They are adding more high-value steps where a small defect can wreck a very expensive package. Onto sits directly in that problem set through packaging inspection, 3D metrology, optical critical dimension tools, and software that helps customers monitor process drift across increasingly complex device architectures.
The setup is already backed by real demand. Onto delivered record 2025 revenue of $1.005 billion, then guided first-quarter 2026 revenue to $275 million to $285 million. More importantly, the company has landed specific proof points in the most interesting lane: a $240 million volume purchase agreement through 2027 with a leading memory manufacturer for its advanced-packaging portfolio, and double-digit orders for the new Dragonfly G5 system selected by a leading logic customer for HBM4 production ramp. The real investment question is whether advanced packaging and leading-edge node control stay strong enough that Onto earns a more durable, infrastructure-like multiple rather than a standard semi-tool multiple. If yes, the stock can still work well from here. If no, it falls back into a high-quality but more ordinary process-control name.
Onto is clearly winning in advanced packaging and process control. The real question is whether those packaging and HBM ramps are durable enough to support a longer, higher-quality earnings cycle than the market normally grants a process-control name.
Valuation and financials
The 4Ps
CEO Mike Plisinski has kept Onto pointed at process-control categories where the value of the tool rises with device complexity. That matters because the best growth lanes are not generic. They are packaging inspection, HBM, and high-end node control. Onto does not need to be everything. It needs to keep winning where the bottlenecks are becoming more valuable.
The product story is now especially strong around the packaging stack. Dragonfly G5 is aimed at high-sensitivity optical inspection for advanced packaging, while Atlas G6 targets optical critical dimension metrology for advanced-node control. That is a useful combination because the company can participate in both packaging-driven yield problems and front-end node complexity instead of relying on only one process-control niche.
The bull case is not simply more capital spending. It is that HBM, chiplets, and more advanced nodes cause Onto's served markets to grow faster and stay richer than a normal process-control cycle. If that happens, revenue quality and margins can remain elevated longer than investors typically assume for a semiconductor-equipment name.
The recent volume purchase agreement and named product selections help visibility. But Onto still serves a concentrated semiconductor customer base. In 2025, its top three customers represented 20%, 15%, and 14% of revenue. So the setup is better than a pure spot-order story, but concentration still matters.
Portfolio manager lens
Starting point: Onto is one of the cleaner ways to own advanced-packaging and HBM process control without taking a direct memory or logic-product bet.
What is in the stock: record 2025 revenue, a multi-year $240 million agreement, Dragonfly G5 HBM4 traction, and the view that packaging inspection stays structurally stronger than a normal process-control niche.
What can still surprise upside: more high-value packaging wins, broader Atlas G6 adoption, and proof that the advanced-packaging cycle stays rich into 2027.
What changes the view: customer concentration biting harder, packaging demand narrowing to too few ramps, or new-product traction failing to translate into durable revenue quality.
Trade framing
This is no longer an undiscovered packaging name. The market already knows Onto is one of the better advanced-packaging process-control stories. The better setup from here is around proof that the demand is both durable and valuable.
The next checkpoints are simple: does first-quarter 2026 revenue land near the $275 million to $285 million guide, do Dragonfly G5 and Atlas G6 continue converting into orders and revenue, and does the volume purchase agreement turn into a stable multi-quarter base rather than a one-off headline? If yes, the stock can continue earning premium treatment. If not, it reverts to a strong niche tool story with more cyclical framing.
What matters now
What matters now is whether Onto's recent advanced-packaging wins turn into a durable 2026-2027 revenue bridge rather than a strong burst of launch activity. The real checkpoints are the $240 million volume agreement converting into visible multi-quarter packaging revenue, Dragonfly G5 proving it can spread beyond a single HBM4 ramp, and Atlas G6 becoming a broader node-control franchise across both logic and memory. If those three proof points keep landing while margins stay rich, the stock can still earn a better process-control multiple from here. If they do not, the story starts looking more like a very good packaging moment than a longer-duration platform win.
Key questions
Onto sells process-control tools and software used in semiconductor manufacturing. In practice that means inspection, metrology, and related analytics that help customers see defects, measure critical dimensions, and monitor process health before yield losses become too costly.
The current product story is especially strong in two places. First is advanced packaging and HBM, where Dragonfly G5 is aimed at high-sensitivity inspection needs. Second is leading-edge front-end control, where Atlas G6 addresses optical critical dimension metrology. So Onto is not a single-lane packaging company. But packaging is where the story currently feels most strategically differentiated.
Thesis last reviewed April 2, 2026. Live data updates automatically.